心脉医疗 to acquire remaining 72.37% stake in OMD for $65M

心脉医疗's subsidiary MICROPORT ENDOVASTEC B.V. will acquire the remaining 72.37% stake in Optimum Medical Device Inc. (OMD) for $65 million, making OMD a wholly owned subsidiary. OMD holds Lombard Medical, which makes aortic stent graft products.

“通过本次交易，OMD将成为公司的全资子公司，有利于加强公司在主动脉介入医疗器械研发、生产、销售等领域的协同”beta.zhitongcaijing.com

• 1 source
• beta.zhitongcaijing.com心脉医疗(688016.SH)拟6500万美元受让联营公司OMD剩余72.37%股权Jul 1, 2024

Summarized from public sources; check the original articles before acting on it.